相关实验视频
Updated: Jul 9, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
患者的自我注射糖尿病治疗的经验:一个现象学研究
Frans N Ndara1, Vistolina Nuuyoma1
1School of Nursing and Public Health, Faculty of Health Sciences and Veterinary Medicine, University of Namibia, Rundu, Namibia.
Health SA = SA Gesondheid
|November 29, 2023
概括
接受自我注射糖尿病治疗的患者面临着积极和消极的经历,包括孤独和耻辱感. 加强家庭和医疗保健提供者的支持对于有效管理糖尿病至关重要.
科学领域:
- 糖尿病管理 糖尿病管理
- 患者体验研究 研究研究
- 质量健康研究 质量健康研究
背景情况:
- 糖尿病诊断带来了重大的健康,社会,伦理和文化影响.
- 自主注射糖尿病治疗为患者带来了独特的挑战和经验.
- 了解生活经验对于开发有效的应对机制和减少疾病负担至关重要.
研究的目的:
- 探索和描述使用糖尿病 (1型和2型) 自注射治疗的患者的生活经验.
主要方法:
- 在纳米比亚的隆都卫生区使用的现象学定性设计.
- 数据通过非结构化个人访谈收集,对10名故意选择的患者进行了采访.
- 解释性现象学分析用于理解患者的体验.
主要成果:
- 自我注射治疗具有成本效益,并促进自我护理,但导致"孤独的旅程"与不确定性和自我耻辱.
- 患者在注射技术,药物储存和医疗废物处理方面遇到挑战.
- 经验包括自我照顾的积极方面和负面的心理社会影响.
结论:
- 患者报告了自我注射糖尿病治疗的积极和消极生活经历.
- 建议包括加强家庭支持和加强医疗保健工作者的教育.
- 研究结果支持患者教育,应对策略和跨部门合作的发展.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
181
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181
Insulin Formulations: Types and Delivery
202
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
202
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K

